Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2023 Filed Jan 4, 2023 19:17 UTC GrantRestricted Stock Units · Derivative 380 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-000159 · form4.xml · derivative · entry 5

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380

Underlying: Humana Common · 380 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 19:17 UTC GrantRestricted Stock Units · Derivative 380 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-000157 · form4.xml · derivative · entry 5

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380

Underlying: Humana Common · 380 shares

Expires not disclosed

F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 19:14 UTC GrantRestricted Stock Units · Derivative 380 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-000155 · form4.xml · derivative · entry 4

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380

Underlying: Humana Common · 380 shares

Expires not disclosed

F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 17:37 UTC GrantHumana Common 380 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-000124 · form4.xml · nonDerivative · entry 1

JONES DAVID A JR/KY · CIK 0001025393 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380

F5 · balance_after: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/23.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 17:35 UTC GrantHumana Common 380 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-000122 · form4.xml · nonDerivative · entry 1

OBRIEN JAMES J /KY · CIK 0001023582 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,794

F4 · balance_after: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2023.

F3 · ownership.nature: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.

Read SEC document
December 31, 2022 Filed Jan 4, 2023 18:46 UTC GrantRestricted Stock Units · Derivative 2 $510.30 $1,020.59
Disclosure

SEC source: 0001062993-23-000149 · form4.xml · derivative · entry 3

Klevorn Marcy S · CIK 0001692367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2

Underlying: Humana Common · 2 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2022 Filed Jan 4, 2023 23:39 UTC GrantRestricted Stock Units · Derivative 4 $510.30 $2,041.18
Disclosure

SEC source: 0001062993-23-000416 · form4.xml · derivative · entry 3

Bono Raquel C. · CIK 0001823759 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6

Underlying: Humana Common · 4 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2022 Filed Jan 4, 2023 23:37 UTC
KATZ KARENDirector
GrantRestricted Stock Units · Derivative 10 $510.30 $5,102.95
Disclosure

SEC source: 0001062993-23-000412 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20

Underlying: Humana Common · 10 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2022 Filed Jan 4, 2023 19:17 UTC GrantRestricted Stock Units · Derivative 185 $510.30 $94,404.58
Disclosure

SEC source: 0001062993-23-000159 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,015

Underlying: Humana Common · 185 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2022 Filed Jan 4, 2023 19:17 UTC GrantRestricted Stock Units · Derivative 205 $510.30 $104,610.48
Disclosure

SEC source: 0001062993-23-000159 · form4.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,884

Underlying: Humana Common · 205 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2022 Filed Jan 4, 2023 19:17 UTC GrantRestricted Stock Units · Derivative 180 $510.30 $91,853.10
Disclosure

SEC source: 0001062993-23-000157 · form4.xml · derivative · entry 4

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,866

Underlying: Humana Common · 180 shares

Expires not disclosed

F4 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F4 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F4 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F4 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2022 Filed Jan 4, 2023 19:14 UTC GrantRestricted Stock Units · Derivative 4 $510.30 $2,041.18
Disclosure

SEC source: 0001062993-23-000155 · form4.xml · derivative · entry 3

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6

Underlying: Humana Common · 4 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 21, 2022 Filed Dec 23, 2022 15:18 UTC SaleHumana Common 15,000 $501.72 $7,525,800.00
Disclosure

SEC source: 0001062993-22-024440 · form4.xml · nonDerivative · entry 4

JONES DAVID A JR/KY · CIK 0001025393 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 42,028

F7 · shares: Shares contributed by the David Jones Jr Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $501.72 per share, using close of business prices on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust.

F4 · ownership.nature: Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.

Read SEC document
December 16, 2022 Filed Dec 19, 2022 17:30 UTC
Huval Timothy S.Chief Administrative Officer
SaleHumana Common 635 $497.71 $316,045.47
Disclosure

SEC source: 0001062993-22-024057 · form4.xml · nonDerivative · entry 7

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,968

F10 · price: Price reported is weighted average sales price.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 2,183 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · derivative · entry 12

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,368

Underlying: Humana Common · 2,183 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 2,464 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · derivative · entry 11

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,465

Underlying: Humana Common · 2,464 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 2,673 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · derivative · entry 10

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 2,673 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Tax withholdingHumana Common 860 $510.02 $438,617.20
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 6

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,040

F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionHumana Common 2,183 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 5

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Tax withholdingHumana Common 970 $510.02 $494,719.40
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 4

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,717

F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionHumana Common 2,464 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 3

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,687

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Tax withholdingHumana Common 1,052 $510.02 $536,541.04
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 2

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,223

F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:38 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionHumana Common 2,673 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 1

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Exercise / conversionRestricted Stock Units · Derivative 345 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · derivative · entry 15

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 690

Underlying: Humana Common · 345 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Exercise / conversionRestricted Stock Units · Derivative 389 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · derivative · entry 14

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 390

Underlying: Humana Common · 389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Exercise / conversionRestricted Stock Units · Derivative 428 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · derivative · entry 13

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 428 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Tax withholdingHumana Common 159 $510.02 $81,093.18
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 6

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,269

F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Exercise / conversionHumana Common 345 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 5

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Tax withholdingHumana Common 179 $510.02 $91,293.58
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 4

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,083

F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Exercise / conversionHumana Common 389 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 3

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Tax withholdingHumana Common 197 $510.02 $100,473.94
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 2

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,873

F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:36 UTC
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
Exercise / conversionHumana Common 428 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 1

Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 511 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · derivative · entry 15

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,024

Underlying: Humana Common · 511 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 366 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · derivative · entry 13

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367

Underlying: Humana Common · 366 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 285 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · derivative · entry 12

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 285 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 238 $510.02 $121,384.76
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 6

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,804

F12 · shares: Disposition reported represents payment for tax liability on shares vesting on 12/15/22, with no value received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 511 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 5

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,042

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 171 $510.02 $87,213.42
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 4

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,531

F12 · shares: Disposition reported represents payment for tax liability on shares vesting on 12/15/22, with no value received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 366 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 3

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,702

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 133 $510.02 $67,832.66
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 2

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,336

F12 · shares: Disposition reported represents payment for tax liability on shares vesting on 12/15/22, with no value received in return.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:31 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 285 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 1

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,469

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:03 UTC
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
Exercise / conversionRestricted Stock Units · Derivative 261 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024063 · form4.xml · derivative · entry 4

Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 523

Underlying: Humana Common · 261 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:03 UTC
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
Tax withholdingHumana Common 79 $510.02 $40,291.58
Disclosure

SEC source: 0001062993-22-024063 · form4.xml · nonDerivative · entry 2

Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182

F4 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/22.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:03 UTC
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
Exercise / conversionHumana Common 261 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024063 · form4.xml · nonDerivative · entry 1

Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:02 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Exercise / conversionRestricted Stock Units · Derivative 308 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024061 · form4.xml · derivative · entry 14

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 618

Underlying: Humana Common · 308 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:02 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Exercise / conversionRestricted Stock Units · Derivative 329 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024061 · form4.xml · derivative · entry 13

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329

Underlying: Humana Common · 329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:02 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Exercise / conversionRestricted Stock Units · Derivative 357 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024061 · form4.xml · derivative · entry 12

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 357 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:02 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Tax withholdingHumana Common 139 $510.02 $70,892.78
Disclosure

SEC source: 0001062993-22-024061 · form4.xml · nonDerivative · entry 6

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,944

F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/22.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:02 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Exercise / conversionHumana Common 308 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-024061 · form4.xml · nonDerivative · entry 5

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,083

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 18:02 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Tax withholdingHumana Common 149 $510.02 $75,992.98
Disclosure

SEC source: 0001062993-22-024061 · form4.xml · nonDerivative · entry 4

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,775

F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/22.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.